Patents by Inventor David Carroll

David Carroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11405207
    Abstract: The disclosed exemplary embodiments include computer-implemented systems, apparatuses, and processes that dynamically implement and manage hash-based consent and permissioning protocols. By way of example, an apparatus may obtain consent data that identifies one or more elements of data accessible to an application program executed by a device. The apparatus may generate a consent document for the application program based on at least a portion of the consent data, and may compute a consent hash value representative of the consent document. The apparatus may also generate and transmit permissioning data that includes at least the consent hash value to the device. The permissioning data may, for example, include information that instructs the executed application program to store the consent hash value within a local memory of the device and to associate the consent hash value with an access token of the executed application program.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: August 2, 2022
    Assignee: The Toronto-Dominion Bank
    Inventors: Milos Dunjic, Arthur Carroll Chow, David Samuel Tax, Armon Rouhani, Keith Sanjay Ajmani, Gregory Albert Kliewer, Anthony Haituyen Nguyen, Martin Albert Lozon, Kareem El-Onsi, Ashkan Alavi-Harati, Arun Victor Jagga
  • Patent number: 11395134
    Abstract: A computer system for selectively enabling a data transfer method is disclosed. The computer system includes a processor, a communications module, and a memory. The memory stores instructions that, when executed by the processor, cause the computer system to: receive a signal from a remote electronic device via a network using the communications module, the received signal representing information including a context for a transfer of value between a database record associated with a data sender and a database record associated with a data receiver, the context including an identifier for the data receiver; obtain a condition to be satisfied in performing the transfer of value based on the identifier for the data receiver; determine that the condition is satisfied by performing the transfer of value using a particular data transfer method; and enable the transfer of value using the particular data transfer method.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: July 19, 2022
    Assignee: The Toronto-Dominion Bank
    Inventors: Milos Dunjic, Perry Aaron Jones Haldenby, Arthur Carroll Chow, Anthony Haituyen Nguyen, Het Anand Patel, Casey Lyn Doyle, Yubing Liu, John Jong-Suk Lee, David Samuel Tax, Arun Victor Jagga
  • Publication number: 20220098181
    Abstract: The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
    Type: Application
    Filed: November 2, 2021
    Publication date: March 31, 2022
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Sambaiah Thota, David Carroll, Ankush Argade, Kin Tso, Arvinder Sran, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Vanessa Taylor, Robin Cooper, Rajinder Singh, Brian Wong
  • Publication number: 20220073536
    Abstract: The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lupus erythematosus and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 10, 2022
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Rajinder Singh, Ankush Argade, Hui Li, Somasekhar Bhamidipati, David Carroll, Catherine Sylvain, Jeffrey Clough, Holger Keim
  • Publication number: 20220056634
    Abstract: Improved methods, designs and/or systems for incorporating markings and/or other visual and/or tactilely identifiable indicia on woven, knitted, nonwoven, braided and/or felted textiles used for medical textile implants and prostheses, including medical graft prostheses that would not affect the overall mechanical performance of the textile.
    Type: Application
    Filed: September 10, 2021
    Publication date: February 24, 2022
    Inventors: Brian McMurray, Mark Jessup, Tim Warner, Webb Broussard, David Carroll, Morgan Gwaltney
  • Patent number: 11230554
    Abstract: The present invention provides methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lupus erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: January 25, 2022
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Rajinder Singh, Ankush Argade, Hui Li, Somasekhar Bhamidipati, David Carroll, Catherine Sylvain, Jeffrey Clough, Holger Keim
  • Publication number: 20210399245
    Abstract: Composite materials including a thin-film layer of lateral p-n junctions can be employed in circuits or various components of electrical devices. A composite material comprises a thin-film layer including p-type regions alternating with n-type regions along a face of the thin-film layer, the p-type regions comprising electrically conductive particles dispersed in a first organic carrier and the n-type regions comprising electrically conductive particles dispersed in a second organic carrier, wherein p-n junctions are established at interfaces between the p-type and n-type regions.
    Type: Application
    Filed: July 29, 2021
    Publication date: December 23, 2021
    Inventor: David CARROLL
  • Publication number: 20210388261
    Abstract: In one aspect, composite nanoparticles are provided. In some embodiments, a composite nanoparticle comprises a host matrix comprising A4BX6-ZYZ and ABX3-PYP inclusions dispersed within the host matrix of the composite nanoparticle, wherein A is an alkali metal, B is an element selected from the group consisting of transition metals, Group IVA elements and rare earth elements and X and Y are independently selected from Group VIIA elements, 0?z?6, and 0?p<3.
    Type: Application
    Filed: October 16, 2019
    Publication date: December 16, 2021
    Inventors: David Carroll, Junwei Xu
  • Patent number: 11198689
    Abstract: The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
    Type: Grant
    Filed: August 26, 2019
    Date of Patent: December 14, 2021
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, Sambaiah Thota, David Carroll, Ankush Argade, Kin Tso, Arvinder Sran, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Vanessa Taylor, Robin Cooper, Rajinder Singh, Brian Wong
  • Patent number: 11101439
    Abstract: In one aspect, composite materials including a thin-film layer of lateral p-n junctions are described herein, which can be employed in circuits or various components of electrical devices. Briefly, a composite material comprises a thin-film layer including p-type regions alternating with n-type regions along a face of the thin-film layer, the p-type regions comprising electrically conductive particles dispersed in a first organic carrier and the n-type regions comprising electrically conductive particles dispersed in a second organic carrier, wherein p-n junctions are established at interfaces between the p-type and n-type regions. As described further herein, the thin-film layer is flexible, permitting the thin-film to be folded or arranged into a number of configurations to provide various circuits or components of electrical devices.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: August 24, 2021
    Assignee: Wake Forest University
    Inventor: David Carroll
  • Publication number: 20210228757
    Abstract: A device is disclosed. The device contains a first light source configured to excite fluorescence emission of a first contaminant on a surface, and a first optical sensor configured to capture one or more images of the fluorescence emission of the first contaminant.
    Type: Application
    Filed: January 28, 2021
    Publication date: July 29, 2021
    Inventors: Fartash Vasefi, Kenneth Edward Barton, Nicholas Bennett MacKinnon, David Carroll, Sava Marinkovich
  • Publication number: 20210151199
    Abstract: A tool for synchronous and asynchronous communication between a patient, such as a pandemic patient, a plurality of healthcare providers, one or more EMR/EHR systems, and one or more third-party service provider systems includes a server operating one or more processors in communication with patient, healthcare provider, third-party service provider, and channel databases, along with a management engine executing a database management module, a rule module, and a GUI module configured to display a GUI having a plurality of preconfigured, interactive screens to users operating at least one healthcare provider terminal and a patient terminal. The management engine may send and receive synchronous and asynchronous communications between the patient, the healthcare providers, the EMR/HER systems, and the third-party service provider systems via a dedicated patient channel and display the communications upon the GUI screens, generating a healthcare transcript on the continuing patient channel.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 20, 2021
    Inventors: Kevin McGarvey, Jason Sperling, Tom Piekos, David Carroll, Michael Hellein
  • Patent number: 10941134
    Abstract: Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by “B”, T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: March 9, 2021
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Dane Goff, Donald Payan, Rajinder Singh, Simon Shaw, David Carroll, Yasumichi Hitoshi
  • Publication number: 20200355032
    Abstract: In embodiments, a drilling rig system includes a rig unit having rig equipment and a rig electrical subsystem configured for electrical communication with the rig equipment and including a rig electrical subsystem input transformer, an electrical system including a primary power supply subsystem remote from the rig unit, and an intermediate electrical subsystem.
    Type: Application
    Filed: July 27, 2020
    Publication date: November 12, 2020
    Applicant: ORION HOLDCO LLC
    Inventors: Norman S. Myers, David Carroll
  • Patent number: 10724306
    Abstract: In embodiments, a drilling rig system includes a rig unit having rig equipment and a rig electrical subsystem configured for electrical communication with the rig equipment and including a rig electrical subsystem input transformer, an electrical system including a primary power supply subsystem remote from the rig unit, and an intermediate electrical subsystem.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: July 28, 2020
    Assignees: Integrated Drive Systems, LLC, Orion Holdco LLC
    Inventors: Norman S. Myers, David Carroll
  • Publication number: 20200181130
    Abstract: The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
    Type: Application
    Filed: August 26, 2019
    Publication date: June 11, 2020
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Hui Li, sambaiah Thota, David Carroll, Ankush Argade, Kin Tso, Arvinder Sran, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Vanessa Taylor, Robin Cooper, Rajinder Singh, Brian Wong
  • Patent number: D955982
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: June 28, 2022
    Assignee: GOOGLE LLC
    Inventors: Gina Reimann, Luke David Mastrangelo, Maj Isabelle Olsson, Idil Girard, Peter Michael Cazalet, Benjamin Caleb Carroll, Shameem Hameed, Sandeep Singh Waraich
  • Patent number: D956018
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: June 28, 2022
    Assignee: GOOGLE LLC
    Inventors: Gina Reimann, Luke David Mastrangelo, Maj Isabelle Olsson, Idil Girard, Peter Michael Cazalet, Benjamin Caleb Carroll, Troy Edwards, Maura Aranguren, Eric Dayringer, Sandeep Singh Waraich, Shameem Hameed
  • Patent number: D956019
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: June 28, 2022
    Assignee: GOOGLE LLC
    Inventors: Gina Reimann, Luke David Mastrangelo, Maj Isabelle Olsson, Idil Girard, Peter Michael Cazalet, Benjamin Caleb Carroll, Troy Edwards, Maura Aranguren, Eric Dayringer, Sandeep Singh Waraich, Shameem Hameed
  • Patent number: D956020
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: June 28, 2022
    Assignee: GOOGLE LLC
    Inventors: Gina Reimann, Luke David Mastrangelo, Maj Isabelle Olsson, Idil Girard, Peter Michael Cazalet, Benjamin Caleb Carroll, Troy Edwards, Maura Aranguren, Eric Dayringer, Sandeep Singh Waraich, Shameem Hameed